Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a mid-cap US stock, returning 13,365.6%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 13,365.57% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,220.86% |
United States Antimony (UAMY) | 838.76% |
TMC the metals (TMC) | 837.72% |
Centrus Energy (LEU) | 493.51% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 423.95% |
Ramaco Resources (METC) | 415.79% |
Forward Industries (FORD) | 402.66% |
Energy Fuels (UUUU) | 352.76% |
Opendoor Technologies (OPEN) | 347.38% |
Applied Digital (APLD) | 336.18% |
Ondas (ONDS) | 332.4% |
Cidara Therapeutics (CDTX) | 328.44% |
Cipher Mining (CIFR) | 320.25% |
GRAIL, LLC (GRAL) | 295.29% |
ViaSat (VSAT) | 294.32% |
Sandisk (SNDK) | 283.94% |
Planet Labs PBC (PL) | 272.86% |
Mineralys Therapeutics, Inc Common Stock (MLYS) | 249.15% |
Uniqure (QURE) | 247.45% |
Sibanye Gold Ltd ADR (SBSW) | 245.75% |
Bitfarms (BITF) | 245.51% |
Eos Energy Enterprises (EOSE) | 242.37% |
DRDGOLD Limited ADR (DRD) | 241.95% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
